We’ve updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.

#What Are the Key Projections for the CAGR of the Sartans Market Size From 2025 to 2034?#_x000D_

The market size of sartans has been witnessing consistent growth over the past few years. The market is projected to expand from $21.36 billion in 2024 to $22.39 billion in 2025, with a compound annual growth rate (CAGR) of 4.8%. Factors such as the surge in sedentary lifestyles, growing instances of obesity, heightened awareness of cardiovascular diseases, escalation in healthcare investment and the increasing demand for generic antihypertensive drugs contributed to its growth during the historic period._x000D_

_x000D_

The sartans market is predicted to witness consistent expansion in the forthcoming years, ascending to a value of $26.66 billion by 2029 with a Compound Annual Growth Rate (CAGR) of 4.5%. This progression during the projected period is linked to a growing interest in combination therapies, escalated investment in pharmaceutical research and development, an increased requirement in blossoming markets, an evolving healthcare infrastructure, and an escalating frequency of disorders related to lifestyle. Key trends anticipated during this period consist of progress in drug delivery technologies, enhanced manufacturing procedures for APIs, the evolution of fixed-dose combination drugs, advancements in personalized hypertension treatment and the creation of novel sartan derivatives._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=24393&type=smp_x000D_

_x000D_

#Which Factors and External Forces Are Driving Demand in the Sartans Market?#_x000D_

The proliferation of high blood pressure is anticipated to fuel the expansion of the sartans market in the future. Hypertension, defined by consistently elevated blood pressure, increases the risk of heart disease, stroke, and other serious health issues. The escalating occurrence of hypertension is associated with high salt and processed food diets which result in fluid buildup and heightened strain on the heart. Sartans remedies hypertension by inhibiting the angiotensin II hormone, responsible for constricting blood vessels. It allows the vessels to relax and broaden, reducing blood pressure and decreasing the burden on the heart. For example, the American Heart Association, a non-profit organization based in the U.S., reported in January 2024 that there were 131,454 deaths mainly caused by hypertension in 2022, a jump from 124,508 deaths in 2021. As such, the surging rates of hypertension are spurring the expansion of the sartans market._x000D_

_x000D_

#Which Segments in the Sartans Offer the Most Growth?#_x000D_

The sartans market covered in this report is segmented –_x000D_

_x000D_

1) By Product Type: Valsartan, Telmisartan, Losartan, Irbesartan, Azilsartan, Olmesartan_x000D_

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels_x000D_

3) By Application: Hypertension, Cardiovascular Diseases, Kidney Diseases, Other Applications_x000D_

4) By End-User: Hospitals, Diagnostic Laboratories, Other End-Users_x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=24393&type=smp_x000D_

_x000D_

#What Are the Fastest-Growing Geographies in the Sartans Market?#_x000D_

North America was the largest region in the sartans market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sartans market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Which Cutting-Edge Market Trends Are Expected to Drive the Sartans Market’s Growth?#_x000D_

Leading firms in the sartans market are concentrating their efforts on producing sophisticated products like sartans in tablet form, to improve treatment effectiveness and patient compliance. The tablet-form sartans are oral drugs containing sartan medications that counteract the influence of angiotensin II, aiding in the dilation of blood vessels and lowering blood pressure. For example, in July 2024, Zydus Lifesciences, a pharmaceutical company based in India, obtained approval from the US Food and Drug Administration (FDA) for their product, Valsartan Tablets USP (40 mg, 80 mg). Known by the brand name Diovan, these tablets are prescribed for hypertension, heart failure, and to boost survival rates after a heart attack in adults. They are also approved for use with pediatric patients aged one and above._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/sartans-global-market-report_x000D_

_x000D_

#What Are the Key Elements That Define the Sartans Market?#_x000D_

Sartans also known as angiotensin II receptor blockers (ARBs) are medications commonly prescribed to manage high blood pressure (hypertension) and heart failure. They block the action of angiotensin II, a hormone that causes blood vessels to constrict, by promoting relaxation of the vessels, lowering blood pressure, and improving circulation. Sartans help reduce the risk of strokes, kidney damage, and heart attacks in individuals with specific cardiovascular conditions._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=24393&type=smp_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 3156230293_x000D_

Asia +44 2071930708_x000D_

Europe +44 2071930708_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model